Company news

GeneDx Holdings Corp. news in 2024

GeneDx Holdings Corp.'s news releases, calls and decks from 2024, newest first.

View company

GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 15, 2024

GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners

December 4, 2024

GeneDx to Participate in Upcoming Investor Conference

November 21, 2024

GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover

November 18, 2024

GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary

November 17, 2024

New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields

November 6, 2024

GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

November 3, 2024

GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights

October 28, 2024

Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening

October 23, 2024

GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns

October 7, 2024

GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024

October 2, 2024

GeneDx to Participate in Fall Investor Conferences

August 11, 2024

GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights

July 29, 2024

GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients

July 29, 2024

GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024

July 10, 2024

GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients

June 9, 2024

GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients

June 4, 2024

GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

April 28, 2024

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

April 22, 2024

GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024

April 3, 2024

GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

March 13, 2024

GeneDx to Participate in 44th Annual Cowen Health Care Conference

February 25, 2024

GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024

February 19, 2024

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024

January 31, 2024

GeneDx Announces Preliminary 2023 Financial Results

January 7, 2024

Calls in 2024

Decks in 2024